Jabra Enhance Select 700 vs Otofonix Groove

The Jabra Enhance Select 700 is a premium-priced OTC hearing aid available at $1,795, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This behind-the-ear device ranks #26 of 65 OTC hearing aids tested, placing it in the top 38% of the category. In our testing, the Enhance Select 700 showed notable strengths in comfort-related metrics. Own-voice comfort scored a solid 3.7/5, measuring 1.19 points above the category average—a meaningful advantage for wearers sensitive to the sound of their own voice. Feedback handling was excellent at 5.0/5, well above the 4.54 category average, indicating reliable stability during typical wear. Speech performance presented a mixed picture. Speech in quiet scored a solid 3.1/5, sitting 0.27 points above average. However, speech in noise was a weakness at 1.0/5, falling 0.48 points below the category average—an important consideration if challenging listening environments are a priority. Music streaming scored 2.5/5, which is above the category average by 0.58 points but only mixed in absolute terms. At this price point, several alternatives delivered stronger overall performance in our testing, including the Lucid Tala (4.61/5) and Audicus Omni 2 (4.59/5). The Jabra Enhance Select 300 and Lucid Engage also achieved higher scores at lower prices. The Enhance Select 700 may suit those prioritizing own-voice comfort and feedback stability over speech-in-noise performance, but shoppers should weigh these trade-offs carefully given the premium pricing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.